Universitätsfrauenklinik Essen
Welcome,         Profile    Billing    Logout  
 3 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Buderath, Paul
NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting
N/A
212
Europe, Canada, US, RoW
Non-Interventional Study
Mayo Clinic
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023
10/29
10/29
PMMR, NCT04504006: European Collaborative Multicenter Observational Study: Modular Treatment With and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

Recruiting
N/A
500
Europe
Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)
Dr. Paul Buderath
Endometrial Cancer
01/25
01/30

Download Options